[HTML][HTML] Emerging pharmacotherapies for COVID-19

R Salvi, P Patankar - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Abstract Novel Corona-virus Disease 2019 (nCOVID 19) is caused by a novel virulent
corona virus and leads to potentially fatal virulent pneumonia and severe respiratory distress …

Emerging pharmacotherapies for COVID-19

R Salvi, P Patankar - Biomedicine & pharmacotherapy …, 2020 - pubmed.ncbi.nlm.nih.gov
Novel Corona-virus Disease 2019 (nCOVID 19) is caused by a novel virulent corona virus
and leads to potentially fatal virulent pneumonia and severe respiratory distress syndrome. It …

[HTML][HTML] Emerging pharmacotherapies for COVID-19

R Salvi, P Patankar - Biomedicine & Pharmacotherapy, 2020 - ncbi.nlm.nih.gov
Abstract Novel Corona-virus Disease 2019 (nCOVID 19) is caused by a novel virulent
corona virus and leads to potentially fatal virulent pneumonia and severe respiratory distress …

Emerging pharmacotherapies for COVID-19.

R Salvi, P Patankar - 2020 - cabidigitallibrary.org
Abstract Novel Corona-virus Disease 2019 (nCOVID 19) is caused by a novel virulent
corona virus and leads to potentially fatal virulent pneumonia and severe respiratory distress …

Emerging pharmacotherapies for COVID-19.

R Salvi, P Patankar - Biomedicine & Pharmacotherapy …, 2020 - europepmc.org
ABSTRACT Novel Corona-virus Disease 2019 (nCOVID 19) is caused by a novel virulent
corona virus and leads to potentially fatal virulent pneumonia and severe respiratory distress …

[引用][C] Emerging pharmacotherapies for COVID-19

R Salvi, P Patankar - Biomedicine & Pharmacotherapy, 2020 - cir.nii.ac.jp
Emerging pharmacotherapies for COVID-19 | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …